Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2013 it was $41.12M, up 277.6% from the year before. The highest annual figure on record is $41.12M in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $41.12M | +277.6% |
| FY2012 | Dec 31, 2012 | $10.89M | -5.2% |
| FY2011 | Dec 31, 2011 | $11.48M | -31.7% |
| FY2010 | Dec 31, 2010 | $16.81M | -18.3% |
| FY2009 | Dec 31, 2009 | $20.56M | – |
See a number that looks wrong?